AR038853A1 - Una composicion parasiticida inyectable - Google Patents

Una composicion parasiticida inyectable

Info

Publication number
AR038853A1
AR038853A1 ARP030100641A ARP030100641A AR038853A1 AR 038853 A1 AR038853 A1 AR 038853A1 AR P030100641 A ARP030100641 A AR P030100641A AR P030100641 A ARP030100641 A AR P030100641A AR 038853 A1 AR038853 A1 AR 038853A1
Authority
AR
Argentina
Prior art keywords
closantel
injectable
salicylanilide
parasites
parasiticiated
Prior art date
Application number
ARP030100641A
Other languages
English (en)
Inventor
Duffy Sean Dr
Cromie Lillian Dr
William Blakely
Original Assignee
Norbrook Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norbrook Lab Ltd filed Critical Norbrook Lab Ltd
Publication of AR038853A1 publication Critical patent/AR038853A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Una composición inyectable preparada para el tratamiento de animales con parásitos, parásitos que se saben susceptibles a al menos una entre avermectinas, milbemicinas o salicilanilidas, comprende por ejemplo ivermectina en una cantidad comprendida entre el 0,1 y el 10 % (p/v), un solvente seleccionado dentro del grupo consistente en glicerol formal, propilenglicol, polietilenglicol y combinaciones de los mismos, y una salicilanilida tal como closantel en una cantidad tal que la composición inyectable libere alrededor de 2,5 mg de closantel/kg vivo de peso del animal a ser tratado y una especie polimérica seleccionada dentro del grupo consistente en polivinilpirrolidona y copolímeros de bloque de polioxipropileno/polioxietileno, dichas especies poliméricas mejoran la biodisponibilidad de la salicilanilida, por ejemplo, closantel.
ARP030100641A 2002-02-28 2003-02-27 Una composicion parasiticida inyectable AR038853A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0204713A GB2386067A (en) 2002-02-28 2002-02-28 Long-acting parasiticidal composition with improved bioavailability comprising an avermectin or milbemycin, plus a salicylanilide & a polymeric species

Publications (1)

Publication Number Publication Date
AR038853A1 true AR038853A1 (es) 2005-01-26

Family

ID=9931979

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP030100641A AR038853A1 (es) 2002-02-28 2003-02-27 Una composicion parasiticida inyectable

Country Status (4)

Country Link
AR (1) AR038853A1 (es)
AU (1) AU2003205858A1 (es)
GB (1) GB2386067A (es)
WO (1) WO2003072112A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0316377D0 (en) * 2003-07-12 2003-08-13 Norbrook Lab Ltd Parasiticidal composition
US7666444B2 (en) 2004-02-02 2010-02-23 Wyeth Antiparasitic composition
MXPA06014303A (es) 2004-06-07 2007-02-19 Syngenta Participations Ag Metodos para reducir el dano producido por nematodos.
US8362086B2 (en) * 2005-08-19 2013-01-29 Merial Limited Long acting injectable formulations
BRPI0506279B1 (pt) 2005-12-16 2018-01-09 Npa - Núcleo De Pesquisas Aplicadas Ltda Composição sinergística de antihelmínticos e endectocidas
BRPI0705822A2 (pt) * 2007-10-25 2009-06-23 Schering Plough Saude Animal Ltda formulação injetável com ação prolongada e uso de um agente semi-sintético derivado do grupo das avermectinas, em combinação com um polìmero biodegradável
WO2015093924A1 (es) * 2013-12-19 2015-06-25 CASTRO ALDRETE, Jorge Issac Vehículo para la administración de compuestos farmacéuticos
KR102101969B1 (ko) 2017-09-06 2020-04-22 (주)인벤티지랩 목시덱틴을 포함하는 마이크로 입자 및 이의 제조 방법
WO2019050259A1 (ko) * 2017-09-06 2019-03-14 (주)인벤티지랩 목시덱틴을 포함하는 마이크로 입자 및 이의 제조 방법
CN109966438A (zh) * 2019-05-17 2019-07-05 石家庄九鼎动物药业有限公司 一种兽用抗寄生虫药物伊维菌素注射液及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ223200A (en) * 1988-01-15 1989-01-06 Ancare Distributors Anthelmintic compositions containing 2',5-dicloro-4'-nitrosalicylanilide and non aqueous carrier
CN1054504C (zh) * 1993-03-15 2000-07-19 科尔加特·帕尔莫利弗公司 洁牙剂
NZ248486A (en) * 1993-08-24 1996-07-26 Ashmont Holdings Limited Subst Stable anthelmintic formulation containing closantel and one or more avermectins or milbemycins in a glycol based solvent
US6193989B1 (en) * 1997-03-21 2001-02-27 Biogenesis S.A. Long acting injectable parasiticidal composition and the process for its preparation
AUPQ875700A0 (en) * 2000-07-13 2000-08-03 Reflex Research Limited Combination compositions

Also Published As

Publication number Publication date
WO2003072112A1 (en) 2003-09-04
AU2003205858A1 (en) 2003-09-09
GB2386067A (en) 2003-09-10
GB0204713D0 (en) 2002-04-17

Similar Documents

Publication Publication Date Title
AR038852A1 (es) Una composicion parasiticida
ECSP045407A (es) Benzazoles sustituidos y el uso del mismo como inhibidores de quinasa raf
AR069552A1 (es) Formulaciones para el tratamiento de semillas y metodos de uso
GT200300180A (es) Vacunas para enfermedades reproductoras del ganado
AR038853A1 (es) Una composicion parasiticida inyectable
CR7877A (es) Derivados de 4-tetrazolil-4-fenilpiperidina para tratar el dolor
PA8541401A1 (es) Empleo de etoxilatos de alcoholes grasos como favorecedores de la penetracion
ECSP055710A (es) Composición antihelmíntica e inyectable mejoradora de crecimiento
ES2126958T3 (es) Formulaciones de parasiticidas aplicables de forma dermica.
ECSP077153A (es) Métodos y composiciones para la cicatrización de heridas
BR0207585A (pt) Método para melhorar o desempenho de crescimento de um animal, composição promotora do crescimento, e, construção para a liberação in vivo de uma quantidade eficaz de citocina
AR057319A1 (es) Composicion para la administracion topica y metodo para evitar o tratar infeccion o infestacion endoparasitica y ectoparasitica en un animal de sangre caliente
BR0113006A (pt) Método para tratar doença de armazenamento de glicogênio tipo ii num indivìduo e seu uso
AR040205A1 (es) Composicion herbicida
ECSP066360A (es) Composición parasiticida
AR076139A1 (es) Metodo para el tratamiento de cultivos con un pesticida encapsulado.
AR027688A1 (es) Acilsulfimidas heterociclicas, procedimiento para su preparacion, agentes que las contienen y su empleo como agentes para combatir animales perjudiciales
AR014772A1 (es) Una formulacion acuosa que permite la estabilizacion de conjugados de peg-interferon alfa durante y despues de la liofilizacion, proceso para producir un polvo liofilizado, un polvo liofilizado, un proceso para producir una solucion de los conjudados peg-interferon-alfa y un articulo de manufactura
AR052178A1 (es) Combinacion sinergica de sustancias activas herbicidas
AR061830A1 (es) Formulacion liquida no acuosa altamente eficaz de piretroides
AR013067A1 (es) Composiciones insecticidas y acaricidas y proceso para su preparacion.
ES2146226T3 (es) Utilizacion de una composicion celular para el tratamiento de los organismos humanos o animales.
CL2011001775A1 (es) Composicion veterinaria antiparasitaria que comprende doramectina, aceite de algodon, benzoato de bencilo y uno o mas entre conservantes, excipientes y vitamina liposoluble.
ES2150404T3 (es) Composiciones farmaceuticas de tizoxanida y nitozoxanida.
AR043044A1 (es) Composicion antihelmintica

Legal Events

Date Code Title Description
FA Abandonment or withdrawal